Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,912 Cr
down ₹107 Cr vs Mar 2025
- Stocks held
- 30
- unchanged
- Top 10 weight
- 64.5%
- of the portfolio in its ten largest
- Cash & debt
- 0.1%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 18
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In April 2025 it disclosed 30 stocks worth ₹2,912 Cr, down ₹107 Cr from Mar 2025. Its largest positions were Suven Pharmaceuticals Limited (9.7%), Sun Pharmaceutical Industries Limited (9.7%), Cipla Limited (9.5%); the ten largest together made up 64.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 65.9% of its equity. Cash and debt stood at 0.1%. Compared with Mar 2025 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
90%
Top-10 weight is higher than 90% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
1%
Holds more cash than 1% of peers
Holdings in April 2025
Download CSVEvery line the fund disclosed, with the change against Mar 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 9.72%
- Δ weight
- up 0.23 pts
- Value
- ₹283 Cr
- Δ value
- down ₹3.5 Cr
- Status
- Trimmed
- Weight
- 9.66%
- Δ weight
- down 1.11 pts
- Value
- ₹281 Cr
- Δ value
- down ₹44 Cr
- Status
- Trimmed
- Weight
- 9.53%
- Δ weight
- up 0.98 pts
- Value
- ₹278 Cr
- Δ value
- up ₹19.3 Cr
- Status
- Added
- Weight
- 8.16%
- Δ weight
- up 0.18 pts
- Value
- ₹238 Cr
- Δ value
- down ₹3.2 Cr
- Status
- Trimmed
- Weight
- 5.63%
- Δ weight
- up 0.06 pts
- Value
- ₹164 Cr
- Δ value
- down ₹4.3 Cr
- Status
- Trimmed
- Weight
- 4.67%
- Δ weight
- up 0.40 pts
- Value
- ₹136 Cr
- Δ value
- up ₹7 Cr
- Status
- Added
- Weight
- 4.60%
- Δ weight
- up 0.09 pts
- Value
- ₹134 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 4.43%
- Δ weight
- down 0.43 pts
- Value
- ₹129 Cr
- Δ value
- down ₹17.7 Cr
- Status
- Trimmed
- Weight
- 4.29%
- Δ weight
- down 0.09 pts
- Value
- ₹125 Cr
- Δ value
- down ₹7.3 Cr
- Status
- Trimmed
- Weight
- 3.82%
- Δ weight
- down 0.20 pts
- Value
- ₹111 Cr
- Δ value
- down ₹10.2 Cr
- Status
- Trimmed
- Weight
- 3.64%
- Δ weight
- up 0.03 pts
- Value
- ₹106 Cr
- Δ value
- down ₹3 Cr
- Status
- Trimmed
- Weight
- 3.21%
- Δ weight
- down 0.19 pts
- Value
- ₹93.6 Cr
- Δ value
- down ₹9 Cr
- Status
- Trimmed
- Weight
- 3.15%
- Δ weight
- up 0.32 pts
- Value
- ₹91.8 Cr
- Δ value
- up ₹6.3 Cr
- Status
- Added
- Weight
- 2.96%
- Δ weight
- up 0.30 pts
- Value
- ₹86.1 Cr
- Δ value
- up ₹5.8 Cr
- Status
- Added
- Weight
- 2.83%
- Δ weight
- up 0.19 pts
- Value
- ₹82.3 Cr
- Δ value
- up ₹2.8 Cr
- Status
- Added
- Weight
- 2.77%
- Δ weight
- up 0.06 pts
- Value
- ₹80.7 Cr
- Δ value
- down ₹1 Cr
- Status
- Trimmed
- Weight
- 2.58%
- Δ weight
- up 0.09 pts
- Value
- ₹75.2 Cr
- Δ value
- down ₹10 L
- Status
- Held
- Weight
- 2.55%
- Δ weight
- down 0.17 pts
- Value
- ₹74.4 Cr
- Δ value
- down ₹7.9 Cr
- Status
- Trimmed
- Weight
- 1.76%
- Δ weight
- down 0.19 pts
- Value
- ₹51.3 Cr
- Δ value
- down ₹7.5 Cr
- Status
- Trimmed
- Weight
- 1.56%
- Δ weight
- up 0.12 pts
- Value
- ₹45.3 Cr
- Δ value
- up ₹2 Cr
- Status
- Added
- Weight
- 1.50%
- Δ weight
- down 0.30 pts
- Value
- ₹43.7 Cr
- Δ value
- down ₹10.6 Cr
- Status
- Trimmed
- Weight
- 1.21%
- Δ weight
- up 0.02 pts
- Value
- ₹35.1 Cr
- Δ value
- down ₹73 L
- Status
- Trimmed
- Weight
- 1.20%
- Δ weight
- down 0.01 pts
- Value
- ₹35 Cr
- Δ value
- down ₹1.7 Cr
- Status
- Trimmed
- Weight
- 1.02%
- Δ weight
- up 0.06 pts
- Value
- ₹29.7 Cr
- Δ value
- up ₹74 L
- Status
- Added
- Weight
- 0.69%
- Δ weight
- up 0.18 pts
- Value
- ₹20.1 Cr
- Δ value
- up ₹4.5 Cr
- Status
- Added
- Weight
- 0.66%
- Δ weight
- up 0.05 pts
- Value
- ₹19.1 Cr
- Δ value
- up ₹87 L
- Status
- Added
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.59%
- Δ weight
- up 0.03 pts
- Value
- ₹17.1 Cr
- Δ value
- up ₹40 L
- Status
- Added
- Weight
- 0.53%
- Δ weight
- up 0.05 pts
- Value
- ₹15.5 Cr
- Δ value
- up ₹89 L
- Status
- Added
- Weight
- 0.47%
- Δ weight
- down 0.04 pts
- Value
- ₹13.8 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 0.38%
- Δ weight
- down 0.04 pts
- Value
- ₹11 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 0.13%
- Δ weight
- down 0.69 pts
- Value
- ₹3.8 Cr
- Δ value
- down ₹21 Cr
- Status
- Trimmed
- Weight
- 0.09%
- Δ weight
- up 0.02 pts
- Value
- ₹2.6 Cr
- Δ value
- up ₹65 L
- Status
- Added
What changed, Mar 2025 to Apr 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Cipla Limitedup ₹19.3 Cr (+0.98% pts)
- Apollo Hospitals Enterprise Limitedup ₹7 Cr (+0.40% pts)
- Kovai Medical Center and Hospital Limitedup ₹6.3 Cr (+0.32% pts)
- Pfizer Limitedup ₹5.8 Cr (+0.30% pts)
- Thyrocare Technologies Limited ₹4.5 Cr (+0.18% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2025, the weight rose most in Healthcare Services (+0.3 pts) and Healthcare Equipment & Supplies (+0.2 pts), and fell most in Pharmaceuticals & Biotechnology (−0.5 pts) and Pharmaceuticals (−0.1 pts).
- Healthcare Services17.2% → 17.6%+0.3 pts
- Healthcare Equipment & Supplies8.7% → 8.9%+0.2 pts
- Insurance1.5% → 1.6%+0.1 pts
- Pharmaceuticals & Biotechnology66.4% → 65.9%−0.5 pts
- Pharmaceuticals5.7% → 5.6%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2022 | Apr 2024 | Oct 2024 | Jan 2025 | Mar 2025 | Apr 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 55.4% | 71.6% | 66.4% | 63.7% | 66.4% | 65.9% |
| Healthcare Services | 28.0% | 14.0% | 18.0% | 18.9% | 17.2% | 17.6% |
| Healthcare Equipment & Supplies | 5.5% | 6.5% | 8.1% | 10.2% | 8.7% | 8.9% |
| Pharmaceuticals | 7.1% | 5.5% | 5.6% | 5.3% | 5.7% | 5.6% |
| Insurance | 2.5% | 1.8% | 1.5% | 1.4% | 1.5% | 1.6% |
| Retailing | 1.5% | 0.6% | 0.4% | 0.4% | 0.5% | 0.5% |
Allocation in Apr 2025change vs Mar 2025
- Pharmaceuticals & Biotechnology (14)65.9%▼ 0.5 pts
- Healthcare Services (8)17.6%▲ 0.3 pts
- Healthcare Equipment & Supplies (3)8.9%▲ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Apr 2025
0.1%
▼ 0.7 pts vs Mar 2025
- Cash alone
- 0.1%
- cash and net receivables
- A year earlier
- 1.0%
- Apr 2024 · now ▼ 0.9 pts
- Last 12 months
- 0.1% – 5.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.